A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader ...

Ashurst Perkins Coie opens its doors following landmark merger ...

Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of ...

Despite the flexibilities embedded in the TRIPS Agreement and reaffirmed by the Doha Declaration, timely access to vaccines ...

15 June 2026 Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech ...

16 June 2026 In the second of a series of interviews with women judges at the pan-European court, Ulrike Voß talks to Sarah ...

Despite a slowdown in US patent litigation, life sciences remains one of the most active sectors—but companies are using a ...

The court granted Blue Cross Laboratories a permanent injunction after finding that a rival product’s mark and packaging closely mirrored its own.

A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned ...

A unanimous SCOTUS ruling is being hailed as a major win for Hikma, and for delivering some welcome clarity. Experts tell Marisa Woutersen how its implications could affect pharma patent strategy ...

The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.